Meta- and pooled analyses of the effect of glutathione S-transferase M1 and T1 deficiency on chronic obstructive pulmonary disease

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 12, 2008, Pages 1474-1481

  Hu, G ^a   Yao, W ^b   Zhou, Y ^a   Hu, J ^a   Shi, Z ^a   Li, B ^c   Ran, Pixin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Case control study; COPD; Glutathione S transferase; Meta analysis

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL;

DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 58049201705     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Pauwels R A, Buist A S, Calverley P M, et al., on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. National Heart, Lung and Blood Institute/World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. Updated 2006 version at http://www.goldcopd.org/ Accessed October 2008.
2. Mannino D M, Homa D M, Akinbami L J, et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002; 51: 1-16.
3. Farber J L. Mechanisms of cell injury by activated oxygen species. Environ Health Perspect 1994; 102: 17-24.
4. Rahman I, Swatska E, Henry M, et al. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2000; 55: 189-193.
5. Lomas D A, Silverman E K. The genetics of chronic obstructive pulmonary disease. Respir Res 2001; 2: 20-26.
6. Sandford A J, Silverman E K. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype environment interaction. Thorax 2002; 57: 736-741.
7. Mannervik B. The isozymes of glutathione S-transferase. Adv Enzymol 1985; 57: 357-417.
8. Hayes J D, Strange R C. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 1995; 22: 193-207.
9. Groppi A, Coutelle C, Fleury B, et al. Glutathione S-transferase class mu in French alcoholic cirrhotic patients. Hum Genet 1991; 87: 628-630.
10. Harada S, Misawa S, Nakamura T, et al. Detection of GST1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese. Hum Genet 1992; 90: 62-64.
11. Seidegard J, Pero R W, Miller D G, et al. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751-753.
12. Pemble S, Schroeder K R, Spencer S R, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271-276.
13. Korytina G F, Yanbaeva D G, Babenkova L I. Genetic polymorphisms in the cytochromes P-450(1A1,2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children. J Mol Med 2005; 83: 700-710.
14. Yanchina E D, Ivchik T V, Shvarts E I, et al. Gene-gene interactions between glutathione-s transferase M1 and matrix metalloproteinase 9 in the formation of hereditary predisposition to chronic obstructive pulmonary disease. Bull Exp Biol Med 2004; 137: 64-66.
15. Cheng S L, Yu C J, Chen C J, Yang P C. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004; 23: 818-824.
16. Chan-Yeung M, Ho S P, Cheung A H, et al. Polymorphisms of glutathione S-transferase genes and functional activity in smokers with or without COPD. Int J Tuberc Lung Dis 2007; 11: 508-514.
17. Budhi A, Hiyama K, Isobe T, et al. Genetic susceptibility for emphysematous changes of the lung in Japanese. J Mol Med 2003; 11: 321-329.
18. Harrison D J, Cantlay A M, Rae F, et al. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997; 16: 356-360.
19. Yim J J, Park G Y, Lee C T. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000; 55: 121-125.
20. Calikoglu M, Tamer L, Ates Aras N. The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population. Biochem Genet 2006; 44: 307-319.
21. Baranova H, Perriot J, Albuisson E, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 1997; 99: 822-826.
22. Higgins J P, Thompson S G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
24. Baranov V S, Ivaschenko T, Bakay B, et al. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multi-factorial diseases. Hum Genet 1996; 97: 516-520.
25. Korytina G F, Iaibaeva D G, Viktorova T V. Polymorphism of glutathione S-transferase M1 and P1 genes in patients with cystic fibrosis and chronic respiratory tract diseases. Genetika 2004; 40: 401-408.
26. He J Q, Ruan J, Connett J E, et al. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002; 166: 323-328.
27. Zidzik J, Slabá E, Joppa P, et al. Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J 2008; 49: 182-191. [Croatian]
28. Hersh C P, Demeo D L, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33: 71-78.
29. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 (Suppl): S77-S120.
30. International statistical classification of diseases and related health problems. Tenth revision. ICD-10 (1992). Geneva, Switzerland: World Health Organization, 1992.
31. The National Emphysema Treatment Trial Research Group. Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. Chest 1999; 116: 1750-1761.
32. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-2073.
33. Bell B, Rose C L, Damon H. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 1972; 3: 5-17.
34. Celli B R, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
35. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
36. 1 and prevalence of pulmonary conditions in Japanese-American men. Am Rev Respir Dis 1988; 138: 1398-1404.